Flamma USA, part of the Flamma Group, a CDMO that develops, manufactures, and commercializes small molecule APIs for the pharmaceutical industry, has completed the re-commissioning of its High Potent API (HPAPI) suite.   Flamma is confident that this will provide a viable alternative for customers seeking development of early stage HPAPIs since long lead times for other vendors is often problematic. Flamma has undergone an extensive qualification of the HPAPI suite over the past six months in or...